Cargando…

Should every Patient with MDS get Iron Chelation – Probably Yes

Detalles Bibliográficos
Autores principales:	Ghosh, Kanjaksha, Ghosh, Kinjalka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2017
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584764/ https://www.ncbi.nlm.nih.gov/pubmed/28894564 http://dx.doi.org/10.4084/MJHID.2017.055

Ejemplares similares

Iron chelators or therapeutic modulators of iron overload: Are we anywhere near ideal one?
por: Ghosh, Kanjaksha, et al.
Publicado: (2018)

Inherited Thrombocytopenias: Combining High-Throughput Sequencing With Other Relevant Data
por: Ghosh, Kanjaksha, et al.
Publicado: (2019)

Controversies on the Consequences of Iron Overload and Chelation in MDS
por: Vinchi, Francesca, et al.
Publicado: (2020)

Irresistible Persuasion: The Secret Way To Get to Yes Every Time
por: Burch, Geoff
Publicado: (2010)

Hydroxyurea Could Be a Good Clinically Relevant Iron Chelator
por: Italia, Khushnooma, et al.
Publicado: (2013)

Albumin Cobalt Binding or Ischaemia Modified Albumin: a Test of Great Prognostic Value in Malaria
por: Ghosh, Kinjalka, et al.
Publicado: (2017)

Cardionephrology from the point of view of the cardiologist: no more agree to disagree—getting to ‘yes’ for every patient
por: Burlacu, Alexandru, et al.
Publicado: (2021)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Ten facts about monkeypox that every anesthesiologist should know
por: Das, Akshaya K., et al.
Publicado: (2023)

Iron chelation may harm patients with COVID-19
por: Garrick, Michael D., et al.
Publicado: (2020)

Increased Mortality in Male Recipients of Red Cells from ever Pregnant Female Donors: mHAGs on Red Cells to Blame?
por: Ghosh, Kanjaksha
Publicado: (2018)

Fibrosis and bone marrow: understanding causation and pathobiology
por: Ghosh, Kanjaksha, et al.
Publicado: (2023)

Hairfluencer social media trends every dermatologist should know in 2021
por: Paiewonsky, Briana, et al.
Publicado: (2022)

Reply: Iron chelation may harm patients with COVID-19
por: Abobaker, Anis
Publicado: (2020)

Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient
por: Hamdy, Omar
Publicado: (2018)

HIV risk associated with nucleic acid testing tested seronegative blood donation where the donor was not preassessed for the risk
por: Ghosh, Kanjaksha, et al.
Publicado: (2017)

Prostate-thyroid axis: What every anaesthesiologist should know! - A case study
por: Shah, Shagun B., et al.
Publicado: (2023)

Getting to yes : negotiating agreement without giving in /
por: Fisher, Roger, 1922-2012
Publicado: (1991)

Falciparum malaria selected while HIV-1 slaughtered
por: Ghosh, Kanjaksha, et al.
Publicado: (2008)

Possible impact of factor V Leiden genotype on warfarin induced bleeding
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis
por: Yang, Yuan, et al.
Publicado: (2019)

Common source but a rare cause for intraoperative breathing circuit leak: Every anaesthesiologist should be aware of
por: Govindarajulu, Dhanabagyam, et al.
Publicado: (2014)

Translocation t(2;14)(p13;q32) in a case of Ph+ acute lymphoblastic leukemia
por: Kerketta, Lily, et al.
Publicado: (2007)

Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?
por: Abobaker, Anis
Publicado: (2020)

Should depressive patients undergo a regular diabetes screening test?
por: Ghosh, Subhasish, et al.
Publicado: (2013)

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
por: Hoeks, Marlijn, et al.
Publicado: (2020)

Hemodialysis in COVID-19 Patients: Yes or No? A Commentary
por: Hosseini, Amin, et al.
Publicado: (2020)

Root Cause? Yes of course … but then what?
por: Mira Solves, José Joaquín, et al.
Publicado: (2019)

Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload
por: Alavi, Samin, et al.
Publicado: (2014)

Getting Access to the COVID-19 Vaccine: What Should Be Our Approach?
por: Kumar, Subodh, et al.
Publicado: (2021)

A case of histoplasmosis in a patient with MDS/MPN-U
por: Rastogi, Pulkit, et al.
Publicado: (2016)

Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)
por: Vini, Dimitra, et al.
Publicado: (2011)

Impact of labile plasma iron and iron chelation on the viability of cultured mononuclear cells from patients undergoing autologous hematopoietic stem cell transplantation
por: Naoum, Flávio Augusto, et al.
Publicado: (2017)

What every intensivist should know about Tocilizumab
por: Hofmaenner, Daniel Andrea, et al.
Publicado: (2021)

Every reason to discontinue lithium
por: Salgado, Manuel E Fuentes, et al.
Publicado: (2014)

Tissue doppler echocardiography detects preclinical markers of cardiac lesion in MDS patients
por: de Castro, Cláudio César Monteiro, et al.
Publicado: (2012)

Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity
por: Pecankova, Klara, et al.
Publicado: (2022)

Indian Journal of Human Genetics in PubMed: Cautious but confident steps
por: Ghosh, Kanjaksha
Publicado: (2010)

Who should get the vaccine first? A glimpse at COVID-19 vaccination prioritization strategies
por: Askarian, Mehrdad, et al.
Publicado: (2021)

Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?
por: Cortegiani, A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rjh9etqhvds1cittgv99qp1tsj